Designer Liposomic Nanocarriers Are Effective Biofilm Eradicators

[Image: see text] Drug delivery via nanovehicles is successfully employed in several clinical settings, yet bacterial infections, forming microbial communities in the form of biofilms, present a strong challenge to therapeutic treatment due to resistance to conventional antimicrobial therapies. Lipo...

Descripción completa

Detalles Bibliográficos
Autores principales: Kluzek, Monika, Oppenheimer-Shaanan, Yaara, Dadosh, Tali, Morandi, Mattia I., Avinoam, Ori, Raanan, Calanit, Goldsmith, Moshe, Goldberg, Ronit, Klein, Jacob
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9620068/
https://www.ncbi.nlm.nih.gov/pubmed/36018573
http://dx.doi.org/10.1021/acsnano.2c04232

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9620068/
https://www.ncbi.nlm.nih.gov/pubmed/36018573
http://dx.doi.org/10.1021/acsnano.2c04232

Ejemplares similares